H
HST Global Inc
OTC:HSTC
HST Global Inc
OTC:HSTC
Price:
0.99
USD
Market Closed
Market Cap:
$42.3m
Relative Value
There is not enough data to reliably calculate the relative value of HSTC.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HSTC
Relative Value
Base Case
Not Available
Multiples Across Competitors
HSTC Competitors Multiples
HST Global Inc Competitors
HST Global Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
H
|
HST Global Inc
OTC:HSTC
|
42.3m USD | 0 | -482.8 | -500.3 | -500.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
403.2B USD | 6.8 | 171.9 | 16.6 | 23.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.6B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
189.4B USD | 6.4 | 22.3 | 15.1 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.8B USD | 10 | 30.3 | 23.2 | 24.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD | 5.8 | 18.5 | 14.1 | 16.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
73.9B AUD | 3.3 | 17.1 | 11.7 | 14.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.3B EUR | 14.4 | 33.9 | 58.2 | 59.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
